Why Investing $10,000 in NextEra Energy Today Might Just Be a Brilliant Move

Key Points

• NextEra Energy is a company with two businesses.

• The company's regulated utility operations are a reliable foundation.

• NextEra Energy's clean energy division is a growth machine.

• 10 stocks we like better than NextEra Energy ›

If you have $10,000 to invest, a great choice today is NextEra Energy (NYSE: NEE) . That money would buy you approximately 135 shares of what is the largest publicly traded utility in the world, according to recent research by The Motley Fool . But buying NextEra Energy isn't a brilliant move because it is a big utility, it is because it's more than just a utility. Here's what you need to know.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »

What does NextEra Energy do?

NextEra Energy's core business is operating a regulated utility in the state of Florida. Florida Power & Light is one of the largest utilities in the United States. It has long benefited from migration to the Sunshine State. More residents means more paying customers. And more paying customers means more need for the capital spending that keeps supply and demand in balance while also ensuring service reliability.

All of that is important because regulated utilities are granted a monopoly in the regions they serve, but the trade off is that they have to consent to government regulation. Simply put, a regulated utility has to get its rates and investment plans approved by the government. This generally leads to slow and steady growth as regulators balance customer costs with reliable supply and investor returns. The regulated utility business that NextEra Energy operates is a solid, though slow-growth, foundation.

There are lots of companies that fall into the regulated utility bucket. What sets NextEra Energy apart is that on top of this business it has built one of the world's largest solar and wind power companies . Other utilities have tried to do the same thing and fallen short. NextEra Energy, in contrast, has turned this business into a growth engine. This division currently operates around 39 gigawatts of capacity with another 30 gigawatts in its construction backlog. In other words, this division's growth is nowhere near over yet.

The proof of how valuable this combination has been for investors comes from NextEra Energy's dividend. Not only has it increased annually for more than three decades, but the annualized dividend increase over the past decade was a huge 10%. That's good for any company, but it is truly outstanding for a utility. In fact, half that rate of dividend growth would be considered very attractive for this sector.

Why buy NextEra Energy now?

The first reason to like NextEra Energy goes back to its growth as a business. The company has ample opportunity to expand on both the regulated and renewable power sides of its operation. And management expects that this will lead to earnings growth of between 6% and 8% a year through at least 2027. The dividend is projected to increase 10% a year through at least 2026.

The company is so confident in its outlook that management actually wrote "We will be disappointed if we are not able to deliver financial results at or near the top end of our adjusted EPS expectations ranges through 2027" in a recent corporate presentation. That is a confidence-inspiring statement, but only because management has a history of achieving the kind of success it is predicting.

But opportunity for growth and dividend growth is just piece one of the story. The next important reason why you'll want to buy NextEra Energy today is because it looks like an attractive dividend stock, too. The current dividend yield is nearly 3.2%. The S&P 500 index (SNPINDEX: ^GSPC) is only yielding around 1.2% and the average utility's yield is 2.7%. If you are a dividend investor or a growth-and-income investor, NextEra Energy should be highly attractive to you.

NextEra Energy is a differentiated utility

NextEra Energy is not your typical utility, but that's exactly why the stock is so appealing today. Sure, you can find higher yields or stocks with higher dividend growth rates. But a relatively high yield and a high dividend growth rate are a rare combination. If you are looking for a utility, NextEra Energy should be at the top of your list. But it should probably be at the top of the list for anyone who just loves dividends, too.

Should you invest $1,000 in NextEra Energy right now?

Before you buy stock in NextEra Energy, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks For investors to buy now... and NextEra Energy wasn't one of them. The 10 stocks that made the cut could generate monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you had invested $1,000 at the time of our recommendation, you'd have $648,369 !* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,089,583 !*

Now, it is worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 189% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor .

See the 10 stocks »

*Stock Advisor returns as of September 15, 2025

Reuben Gregg Brewer has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends NextEra Energy. The Motley Fool has a disclosure policy .

Read More

This Billionaire Has Bought $442 Million Worth of Nvidia Stock This Year. Does He Know Something We Don't?

Key Points

• Demand for Nvidia's GPUs remains strong.

• Nvidia's management projects massive growth over the next few years.

• Investors can still buy shares and make a fantastic return if management's projections come true.

• 10 stocks we like better than Nvidia ›

Nvidia (NASDAQ: NVDA) has been at the top of the list of best artificial intelligence (AI) stocks to buy over the past few years. Anyone who has bought shares at nearly any time since 2023 has made money, but after the incredible run it has been on, it would be logical to think that there isn't much gas left in the tank.

However, multiple signs point to Nvidia's continued dominance - so much so that some of the largest investors are starting new positions in Nvidia.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »

Daniel Loeb of Third Point began accumulating Nvidia shares at the start of 2025, purchasing $442 million worth over the past two quarters, after owning none at the beginning of 2025. This represents nearly a 6% position sizing within his fund, indicating a clearly bullish bet.

So far, it has worked out well for him, but is there something going on that others don't know about?

Global data center spend is expected to rise dramatically over the next few years

Nvidia manufactures graphics processing units (GPUs) , which are the computing muscle behind today's AI models. GPUs can process multiple calculations in parallel, making them ideal for computing tasks such as AI training and inference.

Although Nvidia has already sold a lot of GPUs, it is scheduled to sell even more over the next few years. The demand for AI computing power has been insatiable so far. Even though the biggest AI hyperscalers plan to spend $600 billion on data center capital expenditures this year and even more next year, Nvidia believes global data center spending can rise to $3 trillion to $4 trillion by 2030.

That's a significant increase, and if this projection proves to be true, it would make Nvidia an even bigger winner for investors.

So if you think you're too late to the party, don't. Even billionaire investors like Daniel Loeb can get in much later than many investors and still benefit from Nvidia's rise.

Additionally, this information is publicly available, so billionaire investors are not acting on any additional information. Nvidia has a lot of room to grow if they are right, but what kind of increase should investors expect?

Nvidia will crush the market if this projection comes true

Using the bottom end of the global data center capital expenditure range of $3 trillion, past performance suggests that Nvidia captures about a third of total revenue. That would indicate revenue of $1 trillion. If Nvidia can maintain its 50% profit margins , that would indicate profits of $500 billion by 2030.

Currently, Alphabet is the most profitable company in the world, generating nearly $116 billion in profits over the past 12 months. For Nvidia to be that much larger is hard to believe, but it's what Jensen Huang and his team at Nvidia are projecting.

If you apply a 30 Price to earnings ratio to this, that indicates that Nvidia would be a $15 trillion company, more than triple from Nvidia's current $4.3 trillion market cap.

That's a major upside, and if Nvidia delivers a triple over the next five years, investors everywhere would benefit due to Nvidia's inclusion in S&P 500 (SNPINDEX: ^GSPC) . Still, because the market tends to double only once every seven years, it would be logical to overweight Nvidia due to its potential upside.

I think Nvidia is as good a buy as it was during any time over the past two and a half years, and investors who believe the AI arms race will continue should be scooping up shares right now. just like billionaire Daniel Loeb did in 2025 .

Should you invest $1,000 in Nvidia right now?

Before you buy stock in Nvidia, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks For investors to buy now... and Nvidia wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you had invested $1,000 at the time of our recommendation, you'd have $648,369 !* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,089,583 !*

Now, it is worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 189% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor .

See the 10 stocks »

*Stock Advisor returns as of September 15, 2025

Keithen Drury has positions in Alphabet and Nvidia. The Motley Fool has positions in and recommends Alphabet and Nvidia. The Motley Fool has a disclosure policy .

Read More

Wall Street Hates REITs — Why That Might Be Good News for You

Pariah Capital is very interested in the real-estate sector, for the simple reason that nobody else is.

The latest BofA Securities Global Fund Manager Survey shows that the world's top money managers have largely given up on real estate and real-estate investment trusts as an asset. "Real estate allocation is 22% underweight (vs 21% net underweight a month ago)," BofA Securities reports. "Current allocation is 1.6 [standard deviations] below its long-term average," it adds, which is another way of saying fund managers' allocation to REITs is unusually low.

They've been dumping real-estate trusts for several months, and net allocation has dropped toward the levels seen briefly last year and, more remarkably, in the wake of the famous real-estate meltdown of the global financial crisis.

This is happening at the same time that investors are pouring money into gold, other metals and cryptocurrencies as "real" assets that are "safe havens" from the insanity threatening paper currencies — especially here in Weimar America. Isn't real estate a "real" asset?

Pariah Capital is this column's tongue-in-cheek occasional series about the follies of investment-manager groupthink. We examine what would happen if you just did the opposite of the big-money crowd. Generally speaking, you would do pretty well .

Financial adviser John Coumarianos, a former real-estate analyst and now CEO of Mindful Advisory in Northvale, N.J., believes U.S. real-estate investment trusts, or REITs, now look "reasonably priced," especially when compared with the rest of the stock market.

The sector currently trades for about 17.5 times annual funds from operations, compared with an average of about 15.5 times since 2000, he says.

It says something ominous about the overall state of euphoria on Wall Street that even the sector most disliked by investors is still not especially cheap.

The one caveat is that the sector's composition has changed over the years," Coumarianos adds. "You're not simply getting multifamily, office, retail, industrial, healthcare and hotels when you buy the index now. The index still contains those property types, but in lower proportion than previously because of the rise of cell towers and data centers.

REITs enjoy a tax-privileged status because they avoid U.S. corporation tax on income they distribute to their investors, so long as they meet certain legal and financial requirements. If you, the investor, own them in a tax shelter such as an IRA, you also avoid tax.

A study a few years ago argued that real estate worldwide had produced higher overall average returns, dating back to 1960, even than stocks.

According to data from the National Association of Real Estate Investment Trusts, U.S. REITs have earned investors a compound annual return of 9.1% per year since the start of 1972.

But nearly all the returns over time have come from the dividends, not from price appreciation. This means investors should look closely at the dividend yield when they buy REITs. Right now the expected yield on the iShares U.S. Real Estate ETF is 4.2%, according to FactSet data. Meanwhile the bond market is predicting inflation of about 2.4% ahead, so investors might factor in a real yield of 1.8%.

Normally, we could compare that to the real yield on Treasury inflation-protected securities, or TIPS, but due to the turmoil at the Bureau of Labor Statistics at the moment, it's not entirely certain that you will be able to depend on official inflation figures, and therefore TIPS real yields, in the future. Only time will tell.

Coumarianos says academic studies raise questions about whether real-estate trusts are truly the portfolio diversifiers many people on Wall Street claim. (This, incidentally, is also true about various other "magic beans" investing products currently being prepared for the public, such as private equity.)

And while REITs typically pay high dividends, those dividends are subject to fluctuations, just like those from other companies. Rolling annual payouts across the REIT sector dropped by almost half during the depths of the global financial crisis, and again during the pandemic.

Doug Ramsey, chief strategist at the Leuthold Group, includes REITs among the seven assets in his clever "All Asset No Authority" portfolio, which spreads its best equally across U.S. large caps, U.S. small caps, international stocks, 10-year U.S. Treasury bonds, gold and commodity futures, as well as REITs.

"REITs are absolutely a valid asset class," he says, adding that they are out of favor, along with other dividend-paying value stocks. "I think there's an opportunity there." (Ramsey says he likes "dividend aristocrats" — companies that have raised their dividends every year for at least 25 years — even more than REITs, but he isn't budging about keeping REITs in the AANA portfolio.)

Investors can go with a straight low-cost REIT index fund such as IYR or the Vanguard Real Estate ETF. Those who specifically want to orient their investment more toward residential real estate have a couple of ETF options, such as iShares Residential & Multi Sector Real Estate ETF, which charges 0.48% a year, and Armada’s Residential REIT ETF, which charges 0.6%.

Whether there is still a strategic long-term case for REITs is a matter of debate. The tactical case for buying some because they are out of fashion looks stronger.

But as always, there are no free lunches.

Read More

Booker's The Reserves 2025: Expensive? Oh yeah. Worth it? Yep

One of the nice things about graduate school was making friends with people who'd eventually have money in their 20s. I was not one of those people, but I occasionally got to drink like it.

That's how Booker's fell into my orbit. It was a bourbon bandied about in the same rarified air of Pappy Van Winkle; tasty, a bit overhyped and ultimately divisive on whether it was worth the cost. While the quality of each pour was rarely in doubt, the value made it a difficult proposition when bourbon nerds drove up the price in a world where you can buy, say, Four Roses at $20 per fifth.

Still, Booker's is a bourbon that will catch my attention when mentioned. So when I had the chance to try this year's version of The Reserves -- an annual release that takes the aged spirit and tweaks it just a bit -- I jumped at it. The 2025 Reserves is finished in the same Booker's barrels that are used to age El Tesoro’s 85th Anniversary tequila, shipped back north to complete nearly nine years of aging. I've never had a bourbon that's been finished in tequila barrels, and apparently this is the first time across the Jim Beam portfolio that's been done.

That's interesting. Is it any good? And, just as importantly, is it worth the $130 price tag?

Booker's The Reserves 2025: A

Despite the tequila barrel influence, the smell off the top is pure bourbon. Inviting, malty, warm and just a little sugary. That sweetness comes through in the form of baking spices; cinnamon, a little nutmeg and a slightly bready feel to what already feels like an absolutely lovely dram.

The first sip is sweet on your tongue, with a little raisin/bread pudding vibe to open things up. Then, the mash kicks in. You get a rewarding spice that highlights the 123 proof spirit inside. You get a complex experience, going from gentle dessert flavors to big, bold malt to an easy landing where that sugar and spice intertwine and give you something to linger on.

Despite a procession of rich flavors, the tequila is subtle. It mainly comes with that sweet finish, where the agave helps soften some of that spice and adds a final layer to an already intense sip. It blends with some of that rye heat to produce a dry, but not intimidating, finish that's very easy to come back to.

While that tequila finish could have been a gimmick, it's a welcome addition here. This was already an expertly made tequila; now it's got a little more color to set it apart.

Either way it works, delivering a smooth, soft sipper that brings some spice at barrel proof but is ultimately rewarding and unique. $130 is a lot to pay for a bottle of bourbon. If you can find The Reserves 2025 and you've got the cash, get it done. That sweet dry finish sings -- especially with a little bit of ice involved.

Would I drink it instead of a Hamm's?

This is a pass/fail mechanism where I compare whatever I'm drinking to my baseline cheap beer. That's the standby from the land of sky-blue waters, Hamm's. So the question to answer is: on a typical day, would I drink Booker's The Reserves 2025 over a cold can of Hamm's?

Sorry, Hamm's. This one's a blowout.

This is part of FTW's Beverage of the Week series. Here, we mostly chronicle and review beers, but happily expand that scope to any beverage that pairs well with sports. Yes, even cookie dough whiskey .

This article originally appeared on For The Win: Booker's The Reserves 2025: Expensive? Oh yeah. Worth it? Yep

Read More

The Crucial Money Mistake Warren Buffett's Mentor Says Could Destroy Your Financial Future

Key Takeaways

• Market enthusiasm creates psychological biases that override rational analysis, leading investors to ignore the fundamentals of the assets they are investing in.
• Even the most experienced traders have suffered significant losses when caught up in investment enthusiasm.

A crucial lesson from Benjamin Graham—the legendary investor who was a dear mentor to Warren Buffett —involves how different investing is from the other things we do: The very trait that drives success in most areas of life can wreck your financial future.

"While enthusiasm may be necessary for great accomplishments elsewhere, on Wall Street it almost invariably leads to disaster," Graham warned in his classic book, "Security Analysis: Principles and Technique." This counterintuitive insight from the man who shaped Buffett's investment philosophy explains why even brilliant investors often fall prey to market bubbles and emotional decision-making.

Curbing Your Enthusiasm

In his " The Intelligent Investor " Graham wrote that Wall Street transforms enthusiasm into a liability, even though it fosters success in other fields.

Market enthusiasm, he argues, functions like "an artificial stimulant" that makes investments seem more attractive, as excessive valuations might be validated by other investors and the fear of missing out ( FOMO ). When investors see others profiting from trending investments, rational analysis is often pushed aside by fear, greed , and, yes, enthusiasm.

This psychological vulnerability affects nearly everyone. As markets rise, enthusiasm creates a self-reinforcing cycle: price increases supposedly confirm existing enthusiasm, drawing more participants, further driving prices upward as herding behavior takes hold—until the inevitable collapse.

Research in behavioral finance shows that during these periods, investors systematically overestimate their ability to sell off without losing too much while underestimating their risks.

Graham noted that even brilliant minds — he refers to Isaac Newton, who lost a fortune in the South Sea Bubble —can fall victim to irrational exuberance .

Stick to preset investment rules and entertain contrarian views can help you avoid enthusiasm-driven mistakes.

Fairy Tales and Failing Scales

Central to Graham's work was his claim that enthusiasm causes investors to lose sight of what is most important to him and Buffett: the actual value of a stock. As the Bulls run on the stock market, conversations shift from fundamentals. Price-to-earnings ratios may soar, say, from 15 to 50 or more, as overenthusiastic investors justify these valuations with tales about exponential growth or revolutionary business models.

When pressed on valuations, enthusiastic investors often respond with some version of "this time is different" or "traditional metrics don't apply here." Investors stop being analysts and become trend followers, often with disastrous consequences when fundamentals do reassert themselves.

Echoing Graham, Buffett once told Berkshire Hathaway Inc.'s ( BRK.A ) shareholders about the dangers of moments: "The line separating investment and speculation , which is never bright and clear, becomes even more blurred when most market participants have recently experienced triumphs. Nothing sedates rationality like large doses of effortless money.

Defense Mechanisms

Here are some safeguards that can help during market run-ups:

• Put in some guardrails : Set specific objective criteria for buying and selling that must be followed, no matter how the market or investor sentiment shifts. This might include maximum valuation thresholds based on financial models or automatic profit-taking rules.
• Record your trades : This goes beyond just listing your trades — your brokerage will have that anyway — to recording why you made them.
• Cultivate skepticism and contrarian thinking . While not every trendy investment is bad, prepare yourself to be especially cautious when ideas become hot topics at social gatherings or dominate social media. As Buffett often repeats, "Be fearful when others are greedy, and greedy when others are fearful."

The Bottom Line

"The market is not a weighing machine" where price tells you exactly the value of something, Graham wrote. "Rather, should we say that the market is a voting machine," reflecting a mix of reason and emotion. Indeed, few saw the dot-com or housing bubbles bursting —until they did.

For both Buffett and Graham, what is central to successful investing is not superior intelligence but the ability to resist the enthusiasm that is so often destructive to portfolios.

Read the original article on newsrealtime

Read More

Astra Pledges $50 Billion for US Manufacturing, Development

(newsrealtime) -- AstraZeneca Plc plans to invest $50 billion in the US before 2030, increasing spending along with other European drugmakers ahead of potential tariffs on imported medicines.

The investment will go toward manufacturing as well as research and development, Astra said in a statement. It includes $4 billion for a new facility in Virginia that will make drugs for chronic diseases, Kevin Hassett, director of the US National Economic Council, said Monday at an event in Washington, DC.

"With the completion of this investment, substantially all of AstraZeneca's pharmaceuticals sold in the United States will be produced in the United States," Hassett said.

With many drugmakers pledging to invest in the US to placate the Trump administration, there is uncertainty around how many commitments are truly new. Astra said the Virginia investment will come on top of $3.5 billion worth of initiatives announced in November.

The shares were little changed in London trading, leaving this year's decline around 2.5%.

Astra will manufacture its experimental weight-loss pill at the facility in Virginia, following an earlier pledge from rival Eli Lilly & Co., which is also planning to produce its obesity pill in the US.

The announcement comes as European drugmakers rush to highlight their US investments in an effort to mitigate the impact of tariffs from President Donald Trump. Astra's previous announcement in November came a week after Trump's election.

Big Spend

Switzerland's Novartis AG in April announced plans for $23 billion in US-based infrastructure spending, while cross-town rival Roche Holding AG said it would invest $50 billion . In May, French drugmaker Sanofi announced intent to invest at least $20 billion in the US by 2030.

Pascal Soriot, who has been chief executive officer of Astra since 2012, has urged tariff restraint from US policymakers. This spring, he recommended that US officials exempt medicines from tariffs, arguing that tax incentives are a better way to attract investment in drug development and manufacturing.

On Monday, Soriot said he understands the need for countries to have medicines manufactured domestically.

It's a question of national security," he said. "This is a vision that the president and his administration have put forward, and a vision that we totally understand, totally support, and the tariffs are accelerating a movement that we would have made anyway.

Trump has proposed various timelines for tariffs on pharmaceuticals, most recently floating Duties that would start as soon as August 1. The president said he expects to give companies a year to bring manufacturing to the US before imposing tariffs as high as 200%.

Meanwhile, Soriot has raised concerns in the UK about his company's commitment to its home country. He has long complained about the regulatory environment, which he says is a threat to hold the nation back from staying competitive with the US and China. In January, Astra abandoned plans for a £450 million ($607 million) vaccine manufacturing plant in Liverpool.

Earlier this month, British paper the Times reported That Soriot is considering moving the company's stock listing to the US. That would be a major blow to the UK's equity markets, which have endured similar defections from other companies in recent years.

"To a great extent, we are American, but we happen to be listed in London and we domicile in London," Soriot said at the event in response to a newsrealtime question about whether Astra plans to move its stock listing to the US.

Under Soriot's leadership, Astra's market value has more than tripled as the company has become a global powerhouse in cancer medicines. It has also built up a significant drug pipeline for other areas, including cardiovascular, renal and metabolic diseases.

--With assistance from Madison Muller.

(Updates with Virginia investment details in the fourth paragraph.)

Most Read from newsrealtime

• Why the Federal Reserve's Building Renovation Costs $2.5 Billion
• Salt Lake City Turns Winter Olympic Bid Into Statewide Bond Boom
• Milan Corruption Investigation Casts Shadow Over Property Boom
• How San Jose's Mayor Is Working to Build an AI Capital

©2025 newsrealtimeL.P.

Read More

Is This the Best Altcoin of July 2025? Under-the-Radar $0.03 Token Prepares for a 150x Takeoff

In a market dominated by legacy giants like Bitcoin (BTC) and Ethereum (ETH), one altcoin is quietly gathering the momentum to become the breakout star of the year. Mutuum Finance (MUTM) , currently in its fifth pre-sale phase at just $0.03, is quickly emerging as a high-potential DeFi infrastructure project. With unique mechanics, real-yield tokenomics, and an upcoming decentralized stablecoin, MUTM could soon become the sleeper altcoin of 2025 - and early investors are already reaping the benefits.

With Phase 5 already 87% sold out and over $12.8 million raised, Mutuum Finance (MUTM) isn't just gathering dust—it's picking up serious speed. More than 13,800 holders and 12,000+ Twitter followers are fueling a fast-growing community around the project. Once this phase ends, the price will jump to $0.035, setting the stage for listings at $0.06. That's a 2x return from the current entry point—before the market even opens up. Security-wise, MUTM has passed CertiK's rigorous audit process, earning a Token Scan score of 95.00 and a Skynet score of 77.50, following both manual and static reviews. These are benchmarks many newer altcoins fail to meet.

Real-Yield Lending and Passive Income That Grows

Mutuum Finance (MUTM)'s upcoming hybrid lending model is what makes it one of the most promising DeFi protocols in development. The platform will support peer-to-contract (P2C) lending for stablecoins and major crypto assets like ETH, BTC, and SOL, alongside a peer-to-peer (P2P) borrowing system tailored for high-volatility tokens like DOGE, SHIB, and PEPE. Once live, a scenario such as depositing 10 ETH—valued at approximately $52,000—at a 65% loan-to-value ratio could generate 6.5 mtETH tokens. These tokens are designed to auto-accrue yield at projected rates of up to 8% APY, potentially delivering $4,160 in passive income annually without selling the original asset.

On the borrower side, the P2P system aims to unlock liquidity from assets that are usually sidelined. For instance, a user holding $1,500 of DOGE could use it as collateral at 20% LTV to borrow stablecoins like 300 USDT instantly. With flexible repayment terms—like a 30-day window at an estimated 12% APY—the protocol is being built to create a healthy risk-reward dynamic for both lenders and borrowers. All of this will be deployed on a Layer 2 blockchain, optimizing gas efficiency and enabling seamless staking of mtTokens via smart contracts to unlock compounded returns.

Audit-Backed Trust, Community Growth, and Last Chance Pricing

Investors are noticing that a known one, who swapped 0.2 BTC back in Phase 1 at $0.01, has already seen her position triple in value—and that's before the token lists at $0.06. Once listed, his holdings are expected to be worth 6x her original investment, a stark contrast to stagnant blue-chip holdings that require market-wide rallies to match those returns.

Security is non-negotiable, and Mutuum Finance (MUTM) takes it seriously. In addition to the CertiK audit, the project has launched a $50,000 bug bounty program covering all severity levels. It's an open invitation for white-hat hackers to test the system and reinforce trust. On the community side, a $100,000 giveaway It is live, with 10 lucky winners each receiving $10,000 worth of MUTM tokens. The team is actively building momentum, with a roadmap that includes beta testing, platform finalization, and exchange listings— all tied to the public token release.

At $0.03, with the next price band at $0.035 fast approaching, this might be the final opportunity to grab MUTM before exchange listings catapult it to a projected $0.06—and beyond. The protocol’s design is structured not for hype, but for long-term adoption, and the reward mechanisms in place make it one of the few presales that actually prioritize holders over headline noise.

If you're still sitting on the sidelines waiting for the next Ethereum (ETH) or Solana (SOL) to emerge, you might be missing the real breakout of 2025. With infrastructure, transparency, and growth potential all aligned, Mutuum Finance (MUTM) isn't just another altcoin—it's the foundation of a smarter DeFi future.

For more information about Mutuum Finance (MUTM), visit the links below:

Website: https://mutuum.com/

Linktree: https://linktr.ee/mutuumfinance

Read More

15 stocks of companies set to grow sales twice as fast as the S&P 500 — analysts love them

Growth stocks can be expensive, but if you are trying to be aggressive with a portion of your investment portfolio, you often have to pay a premium for the privilege.

For example, shares of Intuit Inc., the developer of TurboTax and QuickBooks software, have traded at an average forward price-to-earnings ratio of 35.4 over the past five years through Friday, according to FactSet. That is based on prices divided by rolling consensus 12-month earnings-per-share estimates among analysts polled by FactSet. In comparison, the S&P 500 has traded at an average weighted forward P/E ratio of 20.3 over the past five years. And for that five-year period, Intuit’s stock has returned 168.5%, compared with a return of 110.6% for the S&P 500, both with dividends reinvested.

So this is an example of a stock for which paying the growth premium has been worthwhile, at least for this five-year period.

Screening the S&P 500 for revenue growth

To set up a new screen of stocks within the S&P 500 expected to grow their businesses most rapidly, let's begin by looking at expected compound annual growth rates (CAGR) for sales per share from 2025 through 2027. The estimates are weighted by market capitalization, as is the S&P 500 index. The sectors are sorted by expected sales CAGR, with the full index at the bottom:

Sector	Two-year estimated sales CAGR through 2027	Forward P/E	Forward Price / Sales
Information Technology	7.8%	30.0	8.4
Industrials	6.6%	24.7	2.8
Real Estate	6.5%	17.9	6.3
Communication Services	6.5%	19.7	3.9
Healthcare	6.0%	16.2	1.3
Consumer Discretionary	5.8%	29.3	2.7
Financials	5.3%	16.6	3.5
Utilities	5.1%	18.3	2.7
Materials	4.2%	20.3	2.1
Energy	3.5%	15.1	1.4
Consumer Staples	0.8%	22.5	1.4
S&P 500	5.4%	22.3	3.1
Source: FactSet

The information technology sector is expected to increase revenue most rapidly from 2025 through 2027. It also trades at the highest forward P/E and the highest forward price-to-sales ratio.

So we screened the S&P 500 to list highly rated stocks of companies expected to show high revenue CAGR from 2025 through 2027.

• We trimmed the list to 478 companies covered by at least nine analysts polled by FactSet, for which consensus revenue estimates were available through calendar 2027. The estimates were adjusted by FactSet for any companies whose fiscal reporting periods don't match the calendar.
• Then we cut the list to 56 companies with expected revenue CAGR from calendar 2025 through calendar 2027 of at least 10.8% — twice the expected sales-per-share CAGR for the full S&P 500.
• To narrow down to a highly rated group of stocks, we pared the screen to 36 rated "buy" or the equivalent by the analysts.
• For many of these favored stocks, the share prices are close to the consensus price targets, or even exceed them. Most analysts set 12-month price targets. So we made one more cut to 15 stocks for which consensus price targets were at least 10% higher than Friday's closing prices.

Here are the 15 stocks that passed the screen, sorted by expected revenue CAGR:

Company	Ticker	Two-year estimated sales CAGR through 2027	Forward P/E	July 18 price	Cons. Price target	Implied 12-month upside potential
ServiceNow Inc.	19.2%	52.5	$963.40	$1,100.61	14%
Eli Lilly and Co.	18.4%	29.5	$771.71	$988.17	28%
Trade Desk Inc. Class A	17.8%	81.9	$80.21	$89.15	11%
Insulet Corp.	17.3%	57.6	$284.23	$343.17	21%
First Solar Inc.	15.9%	9.3	$175.85	$198.15	13%
DexCom Inc.	15.0%	36.3	$83.89	$100.84	20%
Micron Technology Inc.	14.9%	9.7	$114.39	$151.91	33%
Uber Technologies Inc.	14.4%	27.7	$90.59	$100.34	11%
Monolithic Power Systems Inc.	14.2%	39.1	$725.24	$796.92	10%
Palo Alto Networks Inc.	13.6%	53.5	$195.78	$214.91	10%
Workday Inc. Class A	13.2%	24.7	$233.06	$298.09	28%
Intuit Inc.	13.0%	32.9	$752.63	$825.31	10%
Chipotle Mexican Grill Inc.	12.4%	40.4	$53.93	$60.69	13%
Capital One Financial Corp.	12.3%	12.1	$218.28	$242.65	11%
Mastercard Inc.	12.0%	31.7	$552.66	$630.65	14%
Source: FactSet

Any stock screen is limited to a small amount of information. If you are considering an investment in an individual company, you should do your own research to form your own opinion about how likely that business is to remain competitive over the next decade, at least. One way to begin that process is to click on the tickers for more information.

Read: Tomi Kilgore's detailed guide to the information available on the newsrealtimequote page

Don’t miss: Only six dividend stocks pass a quality screen — with yields up to 6.58%

Read More

Barring a surprise, Timberwolves look set to 'run it back' with same core

Several of the Timberwolves' competitors in the stacked Western Conference have been busy loading up their rosters this offseason. The Rockets traded for Kevin Durant and made a couple depth additions. The Nuggets acquired Cam Johnson and a few reliable veterans. The Mavericks lucked into the first overall pick, Cooper Flagg. The Lakers signed DeAndre Ayton.

Meanwhile, Tim Connelly and the Wolves appear to be content with what they already have. Their big moves were to sign both Naz Reid and Julius Randle to new long-term contracts to keep them in Minnesota. A week into the offseason, the Wolves have lost one member of their rotation (Nickeil Alexander-Walker) for financial reasons and added zero players who will see major minutes next season. They'll inevitably pick up a cheap free agent or two in the coming weeks, but as of now, their only newcomers are a couple of 18-year-old project big men via the draft.

What that seems to signal is that Connelly wants to "run it back" next season, banking on continuity and internal development from the team's core stars and young players. While that may not be the most exciting offseason path, it's easy to see how it could pay off for Minnesota.

In two of his first three offseasons as the Timberwolves' president of basketball operations, Connelly made a big, calculated swing. In 2022, he sent a major haul to the Jazz to land center Rudy Gobert, pairing him with Karl-Anthony Towns in an unorthodox frontcourt. Last year, right before the start of the season, Connelly stunned the NBA world by sending Towns to the Knicks for Julius Randle, Donte DiVincenzo, and a first-round pick — a move made both for basketball reasons and long-term financial flexibility.

Both times, it took a while for the Wolves to coalesce after the roster shakeup. They had to learn how to play with Gobert, but in his second season in Minnesota, he won his fourth defensive player of the year award and helped the Wolves reach their first conference finals in 20 years. Following the KAT trade, much of this past season was characterized by inconsistency, but Randle found his stride in the spring and helped the Wolves get back to the conference finals as a No. 6 seed.

One potential benefit of not making any seismic change this offseason would be avoiding the adjustment period that often comes after such a move. Randle and DiVincenzo should be ready to hit the ground running in their second seasons in Minnesota now that they have a year of chemistry with their teammates under their belts. Albeit without Alexander-Walker, who has been a key two-way force over the past couple seasons, the Wolves look set to begin next season with almost all of the group that went 25-6 from March 2 through May 14 this year.

It's important to remember that the Wolves' three long-term core pieces — Anthony Edwards, Jaden McDaniels, and Reid — are not finished products. Edwards turns 24 next month and has improved in each of his first five seasons. McDaniels, who turns 25 before the season, took a significant scoring step forward, averaging nearly 15 points per game during this past postseason. Naz Reid is approaching his 26th birthday and may be just entering his prime. Supported by veterans such as Randle, Gobert, and DiVincenzo, the Wolves' trio of mid-20s stars will largely determine the team's potential in the upcoming season and beyond.

And while the loss of Alexander-Walker and the decline of Mike Conley could threaten the Wolves' backcourt stability, reinforcements are already in place. Terrence Shannon Jr., who is a year older than Edwards despite being drafted four years after him, was impressive in the OKC series and will receive many of NAW's minutes next season Rob Dillingham, last year's eighth overall pick, could be set to earn a big role at the point guard position in year two. While Shannon helps replace Alexander-Walker's offense, Jaylen Clark can be called upon when Chris Finch needs more perimeter defense. Even after losing NAW and making no veteran additions, the Wolves already have ten players worthy of rotational minutes in the upcoming season.

The question, of course, is whether or not the roster that's in place is good enough to get the Wolves over the hump in the West. Coming off their championship, the Thunder aren't going anywhere anytime soon. The Nuggets, Mavericks, and Rockets look highly dangerous. The Lakers, Clippers, and Warriors remain in win-now mode. The Spurs and Pelicans could be sneaky. The Grizzlies and Suns are wild cards.

Connelly seems to believe that this Wolves team has what it takes. The plan, unless there's a surprise, is to rely on chemistry and internal development. It may not be flashy, but it could be the right approach as the Wolves aim to win the first championship in franchise history.

Recommended articles

This article was originally published on www.si.com/nba/timberwolves as Barring a surprise, Timberwolves look set to 'run it back' with same core .

Read More

Smart Investors Are Stocking Ruvi AI (RUVI) This Summer, Could It Outshine Dogecoin (DOGE) with a 13,800% ROI Forecast?

Dogecoin has captured the attention of the cryptocurrency market with its meme-based origins and dedicated community, but for serious investors looking for groundbreaking ROI, Ruvi AI (RUVI) is emerging as the smart choice. Analysts are forecasting an astounding 13,800% ROI for Ruvi AI, with its combination of utility-driven solutions , structured growth , and early success setting it apart from speculative tokens.

With $2.1 million raised , over 170 million tokens sold , and a thriving base of over 1,900 holders , Ruvi AI is proving it's more than just hype. Even in its early stages, this AI-integrated blockchain project is ready to challenge Dogecoin for dominance.

Why Ruvi AI Could Surpass Dogecoin in ROI

While Dogecoin has relied heavily on market trends and community-driven surges, Ruvi AI offers something different: real-world applications and utility in high-demand industries . By merging blockchain technology with artificial intelligence (AI) Ruvi AI isn't just a token; it's a tool for solving tangible problems across sectors.

Real-World Applications Drive Ruvi AI’s Value

Ruvi AI goes beyond speculative investment by focusing on practical use cases that create long-term demand for its token. Key applications include:

• Marketing Ruvi AI's AI-powered tools refine ad targeting, optimize campaigns, and maximize ROI, reducing inefficiencies that drain advertising budgets.
• Entertainment Content creators use Ruvi AI's blockchain-secured payment systems and AI-driven analytics to ensure fair compensation and enhance audience engagement.
• Finance With AI and blockchain integration, Ruvi AI offers real-time fraud detection, secure transactions, and enhanced transparency, making it an invaluable resource for financial institutions.

This strong utility ensures Ruvi AI is built for sustained growth, unlike Dogecoin, which relies heavily on investor sentiment.

Presale Success Fuels Investor Confidence

Ruvi AI's presale results highlight its wide appeal and strong market fit. The project has reached notable milestones, including:

• $2.1 million raised , reflecting strong investor interest.
• Over 170 million tokens sold , showcasing significant adoption.
• A rapidly growing community of more than 1,900 holders , indicating early trust in the platform.

This strong start positions Ruvi AI as one of the most exciting opportunities in the crypto market today.

Explosive ROI Potential for Early Investors

Ruvi AI's transparent and structured growth roadmap is one of the reasons analysts are predicting extraordinary returns. At its current Phase 2 presale price of $0.015 , the token provides a low-risk entry point for investors.

Once the presale concludes, the price is guaranteed to rise to $0.07 , delivering an almost 5x ROI immediately. Looking further ahead, analysts project a $1 valuation after listing , equivalent to an incredible 66x ROI . With these projections, Ruvi AI's potential trajectory could see investors enjoying 13,800% ROI , far surpassing the gains offered by Dogecoin.

Amplified Returns Through VIP Investment Tiers

Ruvi AI's VIP investment tiers offer additional rewards for early adopters, significantly enhancing their earning potential. Here’s a breakdown:

VIP Tier 2 ($750 investment, 40% bonus):

• Total tokens received: 70,000 (50,000 base + 20,000 bonus).
• Value at $0.07 per token: $4,900.
• Value at $1 per token: $70,000.

VIP Tier 3 ($2,100 investment, 60% bonus):

• Total tokens received: 224,000 (140,000 base + 84,000 bonus).
• Value at $0.07 per token: $15,680.
• Value at $1 per token: $224,000.

VIP Tier 5 ($9,600 investment, 100% bonus):

• Total tokens received: 1,280,000 (double allocation).
• Value at $0.07 per token: $89,600.
• Value at $1 per token: $1,280,000.

These tiers reward early action and offer unparalleled ROI potential for investors seeking high-growth opportunities.

Unmatched Transparency and Security

Two critical factors in Ruvi AI's success are its commitment to transparency and security. The project underwent a third-party audit by CyberScope , ensuring its smart contracts are safe and reliable for investors.

Ruvi AI has also partnered with the WEEX Exchange , ensuring post-presale liquidity and a smooth trading experience for token holders once it lists. This focus on investor security sets Ruvi AI apart as a dependable choice in a crowded crypto market.

Can Ruvi AI Outshine Dogecoin?

Dogecoin may have its charm, but Ruvi AI is equipped with the tools and strategy for long-term, scalable success . With its robust utility-focused approach , stellar presale milestones, and projections of a 13,800% ROI Ruvi AI isn't just another cryptocurrency; it's a revolution in blockchain integration.

Priced at just $0.015 per token Ruvi AI offers investors a ground-floor opportunity to achieve substantial rewards. Backed by $2.1 million raised , over 170 million tokens sold , and a rapidly expanding base of 1,900 holders , Ruvi AI is proving itself as a credible and scalable contender.

Learn More

Buy RUVI: https://presale.ruvi.io

Website: https://ruvi.io

Whitepaper: https://docs.ruvi.io

Telegram: https://t.me/ruviofficial

Twitter/X: https://x.com/RuviAI

Try RUVI AI: https://web.ruvi.io/register

Read More